Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Antibody Deficiencies”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Testing effectiveness (Phase 2)Study completedNCT01194791
What this trial is testing

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed

Who this might be right for
Primary Systemic Amyloidosis
PETHEMA Foundation 30
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Testing effectiveness (Phase 2)Study completedNCT00003853
What this trial is testing

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT02207556
What this trial is testing

Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial

Who this might be right for
Primary Systemic Amyloidosis
Medical College of Wisconsin 32
Large-scale testing (Phase 3)Study completedNCT01078454
What this trial is testing

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
National Cancer Institute (NCI) 11
Not applicableLooking for participantsNCT01137643
What this trial is testing

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
UNC Lineberger Comprehensive Cancer Center 15,000
Testing effectiveness (Phase 2)Study completedNCT00002849
What this trial is testing

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 93
Testing effectiveness (Phase 2)WithdrawnNCT01531751
What this trial is testing

High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease

Who this might be right for
Primary Amyloidosis of Light Chain Type
Fondazione IRCCS Policlinico San Matteo di Pavia
Early research (Phase 1)Study completedNCT00006362
What this trial is testing

PS-341 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Mayo Clinic
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Not applicableLooking for participantsNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Large-scale testing (Phase 3)Study completedNCT00070382
What this trial is testing

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 14
Not applicableStudy completedNCT00661401
What this trial is testing

Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin

Who this might be right for
Common Variable ImmunodeficiencyAgammaglobulinemia
Federal University of São Paulo 5
Testing effectiveness (Phase 2)Study completedNCT03499808
What this trial is testing

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Who this might be right for
Amorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more
SWOG Cancer Research Network 43
Not applicableUnknownNCT01981785
What this trial is testing

Investigation of Immune Disorders and Deficiencies

Who this might be right for
Primary Immune DeficienciesAutoimmune DiseasesInflammatory Diseases+2 more
O & O Alpan LLC 343
Testing effectiveness (Phase 2)Study completedNCT00003353
What this trial is testing

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT05310604
What this trial is testing

Early Detection of Primary Antibody Deficiencies in Primary Care Facilities by an Algorithm Driven Selection of Serologic Testing in Individuals at Risk.

Who this might be right for
Primary Antibody Deficiencies
UMC Utrecht 104
Testing effectiveness (Phase 2)Study completedNCT00224393
What this trial is testing

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
The Cleveland Clinic 60
Load More Results